Richard Law, Exscientia

Careers in Discovery

Could AI be the key to reducing the high failure rate in drug discovery? This week on Careers in Discovery, we explore this critical question with Richard Law, Chief Business Officer at Exscientia, who has been at the forefront of integrating AI into the Biotech industry for decades.

Richard shares his fascinating career journey, from his early days as a Computational Chemist to his current role leading Business Development in one of the most innovative companies in drug discovery. He offers unique insights into how AI is not only accelerating the process but also increasing the likelihood of success in developing new therapies.

In this episode, Rich and I discuss the transformative potential of AI in drug discovery, explaining how these technologies are changing the game by improving the quality of molecules and enhancing the precision of clinical trials. He also reflects on the challenges of adapting to a rapidly evolving industry and the importance of staying open to new ideas and learning from those around you.

Join us for an inspiring conversation with Richard Law, where we delve into the future of drug discovery and the revolutionary role AI is set to play.